(found 1 matches in 0.001708s)
CD8 T-Cell Reactivity to Islet Antigens Is Unique to Type 1 While CD4 T-Cell Reactivity Exists in Both Type 1 and Type 2 Diabetes
Ghanashyam Sarikonda, Jeremy Pettus, Sonal Phatak, Sowbarnika Sachithanantham, Jacqueline F. Miller, Johnna D. Wesley, Eithon Cadag, Ji Chae, Lakshmi Ganesan, Ronna Mallios, Steve Edelman, Bjoern Peters, Matthias von Herrath
Previous cross-sectional analyses demonstrated that CD8+ and CD4+ T-cell reactivity to islet-specific antigens was more prevalent in T1D subjects than in healthy donors (HD). Here, we examined T1D-associated epitope-specific CD4+ T-cell cytokine production and autoreactive CD8+ T-cell frequency on a monthly basis for one year in 10 HD, 33 subjects with T1D, and 15 subjects with T2D. Autoreactive CD4+ T-cells from both T1D and T2D subjects produced more IFN-γ when stimulated than cells from HD. In contrast, higher frequencies of islet antigen-specific CD8+ T-cells were detected only in T1D. These observations support the hypothesis that general beta-cell stress drives autoreactive CD4+ T-cell activity while islet over-expression of MHC class I commonly seen in T1D mediates amplification of CD8+ T-cells and more rapid beta-cell loss. In conclusion, CD4+ T-cell autoreactivity appears to be present in both T1D and T2D while autoreactive CD8+ T-cells are unique to T1D. Thus, autoreactive CD8+ cells may serve as a more T1D-specific biomarker.